Categories
Posts
- Sima Lev’s lab – Combination Therapy & Drug Resistance
- Treatment advances in metastatic triple-negative breast cancer (TNBC): Addressing the knowledge gap
- Researchers identify regulator of breast cancer development
- Accelerating AXL targeting for TNBC therapy Lohit Khera, Sima Lev
- The Golgi Apparatus and Membrane Contact Sites
- Sima Lev recommend-Prof. Eli Keshet – VEGF/vascular-centered view of the tumor microenvironment and aging
- Sima Lev recommend-Webiner for Immuno-Oncology
- Tethering the assembly of SNARE complexes
- Animal Lectin Galectin 8 – By Hadas Shatz-Azoulay, Yaron Vinik, Roi Isaac, Ulrike Kohler, Sima Lev, Yehiel Zick
- Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
- Weizmann Institute of Science April 2020 Magazine
- Special Guest Seminar With Prof. Boaz Tirosh
- Cancer Immunometabolism 2020 – Minerva-Gentner Symposium
- Sima Lev: Recommended seminar – Prof. Anna Sablina
- Sima Lev – The COG complex and SNARE
- Three lectures by Robert Weinberg, a Professor for Cancer Research at MIT.
- Nir2 expression modulates cell morphology
- Nir2 regulates cell migration and invasion
- Epithelial-Mesenchymal Transition: EMT
- Cell Death & Disease: PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein
- Epithelial-mesenchymal transition (EMT)
- Epithelial mesenchymal transition (EMT)
- Lipid transfer proteins in cancer biology & metastasis